ZYUS Life Sciences (TSXV:ZYUS) Price-to-Owner-Earnings : (As of Jun. 20, 2024)

View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Price-to-Owner-Earnings?

As of today (2024-06-20), ZYUS Life Sciences's share price is C$1.01. ZYUS Life Sciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for ZYUS Life Sciences's Price-to-Owner-Earnings or its related term are showing as below:

TSXV:ZYUS's Price-to-Owner-Earnings is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 24.615
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-20), ZYUS Life Sciences's share price is C$1.01. ZYUS Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.80. Therefore, ZYUS Life Sciences's PE Ratio for today is At Loss.

As of today (2024-06-20), ZYUS Life Sciences's share price is C$1.01. ZYUS Life Sciences's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.50. Therefore, ZYUS Life Sciences's PE Ratio without NRI for today is At Loss.

ZYUS Life Sciences Price-to-Owner-Earnings Historical Data

The historical data trend for ZYUS Life Sciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Price-to-Owner-Earnings Chart

ZYUS Life Sciences Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

ZYUS Life Sciences Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Owner-Earnings	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of ZYUS Life Sciences's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ZYUS Life Sciences's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Price-to-Owner-Earnings falls into.

ZYUS Life Sciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

ZYUS Life Sciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	1.01	/	0.00
	=

ZYUS Life Sciences (TSXV:ZYUS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

ZYUS Life Sciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

ZLSCF:USA

Address

407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8

Website

https://www.zyus.com

ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.

Executives

John Michael Hyshka

Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines